The PP2A-B55α phosphatase is a master regulator of mitochondrial degradation and biogenesis

PP2A-B55α磷酸酶是线粒体降解和生物合成的主要调节因子。

阅读:9
作者:Valentina Cianfanelli ,Monica Nanni ,Samantha Corrà ,Sofia Mauri ,David Sumpton ,Sergio Lilla ,Rossella De Cegli ,Matteo Bordi ,Giacomo Milletti ,Caterina Ferraina ,Arnaldur Hall ,Michele Petraroia ,Valentina Clausi ,Ezio Giorda ,Marco Scarsella ,Alessandra Barbiera ,Giulia Cadeddu ,Marco Colasanti ,Tiziana Persichini ,Kenji Maeda ,Apolinar Maya-Mendoza ,Jiri Bartek ,Chiara Di Malta ,Franco Locatelli ,Sara Zanivan ,Shehab Ismail ,Elena Ziviani ,Francesco Cecconi

Abstract

Mitochondrial homeostasis relies on a tight balance between mitochondrial biogenesis and degradation. Although mitophagy is one of the main pathways involved in the clearance of damaged or old mitochondria, its coordination with mitochondrial biogenesis is poorly characterized. Here, by unbiased approaches including last-generation liquid chromatography coupled to mass spectrometry and transcriptomics, we identify the protein phosphatase PP2A-B55α/PPP2R2A as a Parkin-dependent regulator of mitochondrial number. Upon mitochondrial damage, PP2A-B55α determines the amplitude of mitophagy induction and execution by regulating both early and late mitophagy events. A few minutes after the insult, ULK1 is released from the inhibitory regulation of PP2A-B55α, whereas 2 to 4 hours later, PP2A-B55α promotes the nuclear translocation of TFEB, the master regulator of autophagy and lysosome genes, to support mitophagy execution. Moreover, PP2A-B55α controls a transcriptional program of mitochondrial biogenesis by stabilizing the Parkin substrate and PGC-1α inhibitor PARIS. PP2A-B55α targeting rescues neurodegenerative phenotypes in a fly model of Parkinson's disease, thus suggesting potential therapeutic application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。